Learning from the Americans
Interview with Ole Dahlberg, CEO of Curida Diatec
More personalised breast cancer screening
Can a new genetic test improve breast cancer screening?
Meet our newest members
Get to know the latest additions to our cancer cluster better!
Klynger samarbeider om å styrke investor-arbeidet
Klyngene har en unik rolle i å øke private investeringer til norsk næringsliv.
A leading Norwegian oncology arena
Cancer Crosslinks 2023 attracted more than 300 on-site participants.
GU Ventures visited Oslo Cancer Cluster Incubator
New connections between Oslo and Gothenburg
